dc.contributor.author | SAİP, PINAR MUALLA | |
dc.date.accessioned | 2021-03-03T14:23:53Z | |
dc.date.available | 2021-03-03T14:23:53Z | |
dc.identifier.citation | SAİP P. M. , "Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group", JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, ss.629 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_3947cbea-fe32-457a-9eab-6db799245e9d | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/42526 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group | |
dc.type | Bildiri | |
dc.contributor.department | İstanbul Üniversitesi , Onkoloji Enstitüsü , Onkoloji Enstitüsü | |
dc.identifier.volume | 29 | |
dc.contributor.firstauthorID | 340407 | |